Loading
CB
Calyx Bio-Ventures Inc. Stock: price and insider trades · Canada
Calyx Bio-Ventures Inc.: what insiders have been doing
Every trade that managers of Calyx Bio-Ventures Inc. disclose to SEDI is tracked on this page. Nothing new has been filed by managers of Calyx Bio-Ventures Inc. in twelve months, the latest record being from 27 December 2017.
The full history, which starts in 2016, counts 6 purchases against 4 sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
26
Thresholds
n/a
Buy Volume
€2,197
6 ops. · all time
Sell Volume
€106,240
4 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 27 December 2017
Declarations26 total
500,000 shares@ CA$0.11523.1% of flowCommon SharesTSXSEDI:3105176
27,000 shares@ CA$0.2854.1% of flowCommon SharesTSXSEDI:3103689
223,000 shares@ CA$0.2934.7% of flowCommon SharesTSXSEDI:3103687
250,000 shares@ CA$0.11515.4% of flowCommon SharesTSXSEDI:3103686
100,000 shares@ CA$0.0511.9% of flowCommon SharesTSXSEDI:3092075
100,000 shares@ CA$0.0717.4% of flowCommon SharesTSXSEDI:3081417
11,000 shares@ CA$0.0750.5% of flowCommon SharesTSXSEDI:2932461
Canonical exit: 23 Mar 2017 (T+90)
9,000 shares@ CA$0.080.4% of flowCommon SharesTSXSEDI:2932462
Canonical exit: 23 Mar 2017 (T+90)
2,000 shares@ CA$0.0850.1% of flowCommon SharesTSXSEDI:2929494
Canonical exit: 19 Mar 2017 (T+90)
3,000 shares@ CA$0.080.1% of flowCommon SharesTSXSEDI:2929492
Canonical exit: 19 Mar 2017 (T+90)
5,000 shares@ CA$0.080.2% of flowCommon SharesTSXSEDI:2922538
Canonical exit: 6 Mar 2017 (T+90)
10,000 shares@ CA$0.0750.4% of flowCommon SharesTSXSEDI:2922317
Canonical exit: 6 Mar 2017 (T+90)
250,000 shares@ CA$0.11100.0% of flowCommon SharesTSXSEDI:2917290
150,000 sharesCommon SharesTSXSEDI:2915580
2,000,000 sharesCommon SharesTSXSEDI:2907008
2,000,000 sharesCommon SharesTSXSEDI:2907012
714,286 shares@ CA$0.0727.1% of flowCommon SharesTSXSEDI:2907009
500,000 shares@ CA$0.0616.2% of flowCommon SharesTSXSEDI:2907007
Common SharesTSXSEDI:2907010
500,000 shares@ CA$0.0530.7% of flowCommon SharesTSXSEDI:2906260
500,000 shares@ CA$0.11369.3% of flowCommon SharesTSXSEDI:2906261
Common SharesTSXSEDI:2906259
100,000 sharesCommon SharesTSXSEDI:2904768
1,000,000 shares@ CA$0.1054.9% of flowCommon SharesTSXSEDI:2903737
350,000 shares@ CA$0.05100.0% of flowCommon SharesTSXSEDI:2900414
25 of 26 declarations
About Calyx Bio-Ventures Inc.
Calyx Bio-Ventures Inc. is a biotechnology company focused on developing innovative solutions in the healthcare sector. It is listed on the Toronto Stock Exchange under the symbol XTSE.
